CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Achillion's hepatitis C drug cures all patients in mid-stage trial
Rifamycin-containing regimens may be preferable in latent tuberculosis
Vertex to end sales of hepatitis C drug telaprevir (Incivek)
Intercept drug for non-alcoholic steatohepatitis found effective
View Complete News Library
September 5-6
GALA (GI and Liver Association of the Americas) Conference
Montreal, Canada
September 19-20
GALA (GI and Liver Association of the Americas) Conference
San Francisco, California
October 17-22, 2014
American College of Gastroenterology (ACG)
Philadelphia, PA
November 7-11
The Liver Meeting 2014
Boston, MA
View all Congresses
  Featured Abstracts          
New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response
Delivery of treatment for hepatitis C virus infection in the primary care setting
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection
A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity
Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B
Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling
A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4, and 12 Months of Age
Validation of EncephalApp, Smartphone-based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
Hepatic encephalopathy: how to test and treat
Brain magnetic resonance in hepatic encephalopathy
Sodium benzoate for treatment of hepatic encephalopathy
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
Systematic Review and Meta-Analysis of Adjuvant I131 Lipiodol after Excision of Hepatocellular Carcinoma
Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
Adjuvant Intraarterial Lipiodol or 131I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
          View All Abstracts  
Slide Library
Abstract Library
CME Dinner Meeting
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.